688488 艾迪药业
已收盘 11-22 15:00:01
资讯
新帖
简况
11月22日艾迪药业跌6.34%,财通优势行业轮动混合A基金重仓该股
证券之星 · 11-22 16:21
11月22日艾迪药业跌6.34%,财通优势行业轮动混合A基金重仓该股
艾迪药业11月22日遭主力抛售624万元 环比增加121.28%
市场透视 · 11-22 15:22
艾迪药业11月22日遭主力抛售624万元 环比增加121.28%
艾迪药业跌5% 近期券商看好
智选洞察 · 11-22 14:24
艾迪药业跌5% 近期券商看好
艾迪药业11月21日主力资金流出282万元 连续7日减仓
市场透视 · 11-21 15:20
艾迪药业11月21日主力资金流出282万元 连续7日减仓
艾迪药业11月19日遭主力抛售237万元 环比增加7800.00%
市场透视 · 11-19
艾迪药业11月19日遭主力抛售237万元 环比增加7800.00%
艾迪药业11月15日主力资金流出102万元 连续3日减仓
市场透视 · 11-15
艾迪药业11月15日主力资金流出102万元 连续3日减仓
艾迪药业大幅上涨 获主力净流入703万元
智选洞察 · 11-06
艾迪药业大幅上涨 获主力净流入703万元
艾迪药业(688488)11月4日主力资金净买入1457.42万元
证券之星 · 11-05
艾迪药业(688488)11月4日主力资金净买入1457.42万元
艾迪药业大幅上涨 获主力净流入586万元
智选洞察 · 11-04
艾迪药业大幅上涨 获主力净流入586万元
开源证券:给予艾迪药业买入评级
证券之星 · 11-03
开源证券:给予艾迪药业买入评级
艾迪药业(688488)2024年三季报简析:净利润减87.75%
证券之星 · 11-01
艾迪药业(688488)2024年三季报简析:净利润减87.75%
艾迪药业(688488)9月30日股东户数1.01万户,较上期增加7.06%
证券之星 · 10-31
艾迪药业(688488)9月30日股东户数1.01万户,较上期增加7.06%
华安证券:给予艾迪药业买入评级
证券之星 · 10-31
华安证券:给予艾迪药业买入评级
艾迪药业大幅上涨 获主力净流入149万元
智选洞察 · 10-31
艾迪药业大幅上涨 获主力净流入149万元
艾迪药业(688488)10月30日主力资金净卖出8.23万元
证券之星 · 10-31
艾迪药业(688488)10月30日主力资金净卖出8.23万元
艾迪药业大跌5.10% 2家券商给予增持建议
智选洞察 · 10-30
艾迪药业大跌5.10% 2家券商给予增持建议
艾迪药业10月28日遭主力抛售327万元 环比增加136.96%
市场透视 · 10-28
艾迪药业10月28日遭主力抛售327万元 环比增加136.96%
艾迪药业10月25日遭主力抛售138万元 环比增加193.62%
市场透视 · 10-25
艾迪药业10月25日遭主力抛售138万元 环比增加193.62%
艾迪药业:10月21日至10月22日高管王军减持股份合计27.22万股
证券之星 · 10-22
艾迪药业:10月21日至10月22日高管王军减持股份合计27.22万股
艾迪药业(688488.SH)董事兼副总裁王军完成减持69.21万股
智通财经 · 10-22
艾迪药业(688488.SH)董事兼副总裁王军完成减持69.21万股
加载更多
公司概况
公司名称:
江苏艾迪药业股份有限公司
所属行业:
其他制造业
上市日期:
2020-07-20
主营业务:
江苏艾迪药业股份有限公司主营业务以为HIV为主的抗病毒业务及人源蛋白业务。主要产品有乌司他丁、尤瑞克林、尿激酶等人源蛋白产品以及蜡样芽孢杆菌片、番泻叶颗粒、头孢拉定胶囊等制剂。公司荣获“2023年度扬州民营企业创新20强”、荣登“2022年度扬州市创新型企业50强”名单及“2022年度中国小分子药物企业创新力TOP30排行榜”。
发行价格:
13.99
{"stockData":{"symbol":"688488","market":"SH","secType":"STK","nameCN":"艾迪药业","latestPrice":9.16,"timestamp":1732258801000,"preClose":9.78,"halted":0,"volume":6103829,"delay":0,"floatShares":421000000,"shares":421000000,"eps":-0.2485,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.62,"latestTime":"11-22 15:00:01","open":9.72,"high":9.78,"low":9.11,"amount":57666200,"amplitude":0.0685,"askPrice":9.16,"askSize":86,"bidPrice":9.15,"bidSize":152,"shortable":0,"etf":0,"ttmEps":-0.2485,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732498200000},"adr":0,"adjPreClose":9.78,"symbolType":"stock_kcb","openAndCloseTimeList":[[1732239000000,1732246200000],[1732251600000,1732258800000]],"highLimit":10.76,"lowLimit":8.8,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":420782808,"pbRate":3.6,"roa":"--","roe":"--","epsLYR":-0.18,"committee":-0.16129,"marketValue":3854000000,"floatMarketCap":3854000000,"peRate":-36.861166,"changeRate":-0.0634,"turnoverRate":0.0145,"status":1,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2024-11-25。","afterMarket":{"amount":0,"volume":0,"close":9.16,"buyVolume":0,"sellVolume":0,"time":1732260839464,"indexStatus":"已收盘 11-22 15:30:00","preClose":9.78}},"requestUrl":"/m/hq/s/688488","defaultTab":"news","newsList":[{"id":"2485023361","title":"11月22日艾迪药业跌6.34%,财通优势行业轮动混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2485023361","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485023361?lang=zh_cn&edition=full","pubTime":"2024-11-22 16:21","pubTimestamp":1732263691,"startTime":"0","endTime":"0","summary":"证券之星消息,11月22日艾迪药业跌6.34%,收盘报9.16元,换手率1.45%,成交量6.1万手,成交额5766.62万元。根据2024基金Q3季报公募基金重仓股数据,重仓该股的公募基金共6家,其中持有数量最多的公募基金为财通优势行业轮动混合A。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112200025875.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0262","688488"],"gpt_icon":0},{"id":"2485238842","title":"艾迪药业11月22日遭主力抛售624万元 环比增加121.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485238842","media":"市场透视","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485238842?lang=zh_cn&edition=full","pubTime":"2024-11-22 15:22","pubTimestamp":1732260121,"startTime":"0","endTime":"0","summary":"11月22日, 艾迪药业股价跌6.34%,报收9.16元,成交金额5766万元,换手率1.45%,振幅6.85%,量比0.90。艾迪药业今日主力资金净流出624万元,上一交易日主力净流出282万元,今日环比增加121.28%。该股近5个交易日下跌1.29%,主力资金累计净流出1455万元,其中3个交易日为股价上涨时净流出;近20日主力资金累计净流出1367万元,其中净流出天数为14日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122154806abd6c4ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122154806abd6c4ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688488","BK0262"],"gpt_icon":0},{"id":"2485285008","title":"艾迪药业跌5% 近期券商看好","url":"https://stock-news.laohu8.com/highlight/detail?id=2485285008","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485285008?lang=zh_cn&edition=full","pubTime":"2024-11-22 14:24","pubTimestamp":1732256691,"startTime":"0","endTime":"0","summary":"11月22日,艾迪药业股价大幅下跌,截至14点24分,艾迪药业下跌5.01%,报9.29元/股,成交4802万元,换手率1.20%,振幅5.01%。资金动向截止发稿,艾迪药业获得主力净流出530万元,其中超大单流出229万元,大单流出300万元。主营业务及业绩艾迪药业公司主营业务为探索、研发和销售创新性化学药物以及人源蛋白产品。最新财报显示,今年三季报,艾迪药业实现营业收入2.99亿元,同比减少0.89%,净利润为-6,094.16万元,同比减少87.75%,基本每股收益为-0.14元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122142504a24d238e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122142504a24d238e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688488","BK0262"],"gpt_icon":0},{"id":"2485458713","title":"艾迪药业11月21日主力资金流出282万元 连续7日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2485458713","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485458713?lang=zh_cn&edition=full","pubTime":"2024-11-21 15:20","pubTimestamp":1732173604,"startTime":"0","endTime":"0","summary":"11月21日, 艾迪药业股价涨0.51%,报收9.78元,成交金额5295万元,换手率1.30%,振幅3.29%,量比0.82。艾迪药业今日主力资金净流出282万元,连续7日净流出,上一交易日主力净流出311万元,今日环比减少9.32%。该股近5个交易日上涨0.72%,主力资金累计净流出933万元;近20日主力资金累计净流出881万元,其中净流出天数为14日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121153142abd40cbe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121153142abd40cbe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688488","BK0262"],"gpt_icon":0},{"id":"2484299535","title":"艾迪药业11月19日遭主力抛售237万元 环比增加7800.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484299535","media":"市场透视","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484299535?lang=zh_cn&edition=full","pubTime":"2024-11-19 15:20","pubTimestamp":1732000854,"startTime":"0","endTime":"0","summary":"11月19日, 艾迪药业股价涨2.28%,报收9.42元,成交金额5950万元,换手率1.54%,振幅5.10%,量比0.77。艾迪药业今日主力资金净流出237万元,连续5日净流出,上一交易日主力净流出3万元,今日环比增加7800.00%。该股近5个交易日下跌7.37%,主力资金累计净流出1701万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出366万元,其中净流出天数为14日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119153604a2450b00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119153604a2450b00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0262","688488"],"gpt_icon":0},{"id":"2483317417","title":"艾迪药业11月15日主力资金流出102万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2483317417","media":"市场透视","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483317417?lang=zh_cn&edition=full","pubTime":"2024-11-15 15:21","pubTimestamp":1731655300,"startTime":"0","endTime":"0","summary":"11月15日, 艾迪药业股价跌4.43%,报收9.28元,成交金额6603万元,换手率1.66%,振幅4.63%,量比0.79。艾迪药业今日主力资金净流出102万元,连续3日净流出,上一交易日主力净流出110万元,今日环比减少7.27%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为41.18%,平均跌幅为4.27%。该股近5个交易日下跌5.31%,主力资金累计净流出699万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出485万元,其中净流出天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115154131abc3b7eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115154131abc3b7eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0262","688488"],"gpt_icon":0},{"id":"2481756691","title":"艾迪药业大幅上涨 获主力净流入703万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481756691","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481756691?lang=zh_cn&edition=full","pubTime":"2024-11-06 09:57","pubTimestamp":1730858260,"startTime":"0","endTime":"0","summary":"11月06日,艾迪药业股价大幅上涨,截至09点57分,艾迪药业上涨5.20%,报9.71元/股,成交3232万元,换手率0.81%,振幅5.74%。资金动向截止发稿,艾迪药业获得主力净流入703万元,其中超大单流入385万元,大单流入317万元。融资融券方面,艾迪药业11月04日获得融资净买入215万元,当日该股融资余额为5263万元,当较前一日增加4.28%,实现4连增;该股融券余额为15万元,融券余量为1.56万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106100844aba39f6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106100844aba39f6a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0262","688488"],"gpt_icon":0},{"id":"2481022560","title":"艾迪药业(688488)11月4日主力资金净买入1457.42万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481022560","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481022560?lang=zh_cn&edition=full","pubTime":"2024-11-05 08:17","pubTimestamp":1730765868,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年11月4日收盘,艾迪药业报收于9.21元,上涨5.02%,换手率2.3%,成交量9.68万手,成交额8833.27万元。近5日资金流向一览见下表:艾迪药业融资融券信息显示,融资方面,当日融资买入707.28万元,融资偿还491.43万元,融资净买入215.85万元,连续3日净买入累计403.77万元。艾迪药业主营业务:专注于医药领域,集药品研发、生产、销售于一体。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110500006942.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688488","BK0262"],"gpt_icon":0},{"id":"2480034345","title":"艾迪药业大幅上涨 获主力净流入586万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480034345","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480034345?lang=zh_cn&edition=full","pubTime":"2024-11-04 10:28","pubTimestamp":1730687292,"startTime":"0","endTime":"0","summary":"11月04日,艾迪药业股价大幅上涨,截至10点28分,艾迪药业上涨5.25%,报9.23元/股,成交3885万元,换手率1.03%,振幅6.96%。资金动向截止发稿,艾迪药业获得主力净流入586万元,其中超大单流入639万元,大单流出52万元。融资融券方面,艾迪药业11月01日获得融资净买入100万元,当日该股融资余额为5047万元,当较前一日增加2.03%,实现3连增;该股融券余额为14万元,融券余量为1.56万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104102847ab9c6128&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104102847ab9c6128&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688488","BK0262"],"gpt_icon":0},{"id":"2480362263","title":"开源证券:给予艾迪药业买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2480362263","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480362263?lang=zh_cn&edition=full","pubTime":"2024-11-03 23:06","pubTimestamp":1730646377,"startTime":"0","endTime":"0","summary":"开源证券股份有限公司余汝意,刘艺近期对艾迪药业进行研究并发布了研究报告《公司信息更新报告:抗艾新药持续放量,收购南大药业打造第二曲线》,本报告对艾迪药业给出买入评级,当前股价为8.77元。目前艾滋病产品临床研究证据不断完善,11次登上柳叶刀等权威学术期刊。最新盈利预测明细如下:该股最近90天内共有5家机构给出评级,买入评级4家,增持评级1家;过去90天内机构目标均价为18.61。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110300001908.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688488","161027"],"gpt_icon":0},{"id":"2480809611","title":"艾迪药业(688488)2024年三季报简析:净利润减87.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480809611","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480809611?lang=zh_cn&edition=full","pubTime":"2024-11-01 06:28","pubTimestamp":1730413680,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期艾迪药业发布2024年三季报。根据财报显示,艾迪药业净利润减87.75%。截至本报告期末,公司营业总收入2.99亿元,同比下降0.89%,归母净利润-6094.16万元,同比下降87.75%。按单季度数据看,第三季度营业总收入1.18亿元,同比上升87.54%,第三季度归母净利润-1550.7万元,同比上升32.16%。持有艾迪药业最多的基金为财通优势行业轮动混合A,目前规模为6.07亿元,最新净值0.6416,较上一交易日上涨0.49%,近一年下跌3.46%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110100006036.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688488"],"gpt_icon":0},{"id":"2479745707","title":"艾迪药业(688488)9月30日股东户数1.01万户,较上期增加7.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479745707","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479745707?lang=zh_cn&edition=full","pubTime":"2024-10-31 17:12","pubTimestamp":1730365969,"startTime":"0","endTime":"0","summary":"证券之星消息,近日艾迪药业披露,截至2024年9月30日公司股东户数为1.01万户,较6月30日增加669.0户,增幅为7.06%。在生物制品行业个股中,艾迪药业股东户数低于行业平均水平,截至9月30日,生物制品行业平均股东户数为3.36万户。从股价来看,2024年6月30日至2024年9月30日,艾迪药业区间跌幅为8.32%,在此期间股东户数增加669.0户,增幅为7.06%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100033887.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688488","BK0262"],"gpt_icon":0},{"id":"2479674528","title":"华安证券:给予艾迪药业买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2479674528","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479674528?lang=zh_cn&edition=full","pubTime":"2024-10-31 11:59","pubTimestamp":1730347191,"startTime":"0","endTime":"0","summary":"华安证券股份有限公司谭国超近期对艾迪药业进行研究并发布了研究报告《HIV新药及新适应症快速推进,南大药业并表》,本报告对艾迪药业给出买入评级,当前股价为8.9元。报告期内公司控股子公司南大药业正式并表。维持“买入”评级。最新盈利预测明细如下:该股最近90天内共有5家机构给出评级,买入评级4家,增持评级1家;过去90天内机构目标均价为18.61。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100022387.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688488","600909"],"gpt_icon":0},{"id":"2479713696","title":"艾迪药业大幅上涨 获主力净流入149万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479713696","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479713696?lang=zh_cn&edition=full","pubTime":"2024-10-31 09:39","pubTimestamp":1730338765,"startTime":"0","endTime":"0","summary":"10月31日,艾迪药业股价大幅上涨,截至09点39分,艾迪药业上涨5.08%,报8.90元/股,成交1558万元,换手率0.42%。资金动向截止发稿,艾迪药业获得主力净流入149万元,其中超大单流入4万元,大单流入144万元。主营业务及业绩艾迪药业公司主营业务为探索、研发和销售创新性化学药物以及人源蛋白产品。最新财报显示,今年三季报,艾迪药业实现营业收入2.99亿元,同比减少0.89%,净利润为-6,094.16万元,同比减少87.75%,基本每股收益为-0.14元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031094016ab878b92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031094016ab878b92&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688488","BK0262"],"gpt_icon":0},{"id":"2479313794","title":"艾迪药业(688488)10月30日主力资金净卖出8.23万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479313794","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479313794?lang=zh_cn&edition=full","pubTime":"2024-10-31 08:19","pubTimestamp":1730333953,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年10月30日收盘,艾迪药业报收于8.47元,下跌6.1%,换手率2.23%,成交量9.36万手,成交额8033.6万元。近5日资金流向一览见下表:艾迪药业融资融券信息显示,融资方面,当日融资买入423.45万元,融资偿还276.04万元,融资净买入147.41万元。艾迪药业主营业务:专注于医药领域,集药品研发、生产、销售于一体。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100011624.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0262","688488"],"gpt_icon":0},{"id":"2479118122","title":"艾迪药业大跌5.10% 2家券商给予增持建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2479118122","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479118122?lang=zh_cn&edition=full","pubTime":"2024-10-30 11:27","pubTimestamp":1730258844,"startTime":"0","endTime":"0","summary":"10月30日,艾迪药业股价大幅下跌,截至11点27分,艾迪药业下跌5.10%,报8.56元/股,成交3686万元,换手率1.00%,振幅4.55%。此外,数据统计显示,近半年内2家券商给予增持建议,6家券商给予买入建议。资金动向截止发稿,艾迪药业获得主力净流出310万元,其中超大单流出62万元,大单流出247万元。融资融券方面,艾迪药业10月28日获得融资净买入2万元,当日该股融资余额为4999万元,当较前一日增加0.06%;该股融券余额为15万元,融券余量为1.80万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030112941a1f74c95&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030112941a1f74c95&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688488","BK0262"],"gpt_icon":0},{"id":"2478127849","title":"艾迪药业10月28日遭主力抛售327万元 环比增加136.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478127849","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478127849?lang=zh_cn&edition=full","pubTime":"2024-10-28 15:20","pubTimestamp":1730100006,"startTime":"0","endTime":"0","summary":"10月28日, 艾迪药业股价涨3.79%,报收9.32元,成交金额6403万元,换手率1.66%,振幅5.35%,量比1.07。艾迪药业今日主力资金净流出327万元,连续4日净流出,上一交易日主力净流出138万元,今日环比增加136.96%。近一年数据显示,该股主力连续4日净流出后,次日下跌概率为72.73%,平均跌幅为2.69%。该股近5个交易日上涨7.00%,主力资金累计净流出484万元;近20日主力资金累计净流出548万元,其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028154629a1f1198e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028154629a1f1198e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688488","BK0262"],"gpt_icon":0},{"id":"2478671394","title":"艾迪药业10月25日遭主力抛售138万元 环比增加193.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478671394","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478671394?lang=zh_cn&edition=full","pubTime":"2024-10-25 15:19","pubTimestamp":1729840788,"startTime":"0","endTime":"0","summary":"10月25日, 艾迪药业股价涨0.67%,报收8.98元,成交金额5640万元,换手率1.50%,振幅3.48%,量比0.95。艾迪药业今日主力资金净流出138万元,连续3日净流出,上一交易日主力净流出47万元,今日环比增加193.62%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为43.75%,平均跌幅为4.27%。该股近5个交易日上涨3.58%,主力资金累计净流出573万元;近20日主力资金累计净流出227万元,其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025154037ab72c643&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025154037ab72c643&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0262","688488"],"gpt_icon":0},{"id":"2477333365","title":"艾迪药业:10月21日至10月22日高管王军减持股份合计27.22万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2477333365","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477333365?lang=zh_cn&edition=full","pubTime":"2024-10-22 20:01","pubTimestamp":1729598499,"startTime":"0","endTime":"0","summary":"证券之星消息,根据10月22日市场公开信息、上市公司公告及交易所披露数据整理,艾迪药业最新董监高及相关人员股份变动情况:2024年10月21日至2024年10月22日公司董事,高级管理人员王军共减持公司股份27.22万股,占公司总股本为0.0647%。变动期间公司股价上涨4.84%,10月22日当日收盘报9.09元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102200032935.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688488","BK0262"],"gpt_icon":0},{"id":"2477877003","title":"艾迪药业(688488.SH)董事兼副总裁王军完成减持69.21万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2477877003","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477877003?lang=zh_cn&edition=full","pubTime":"2024-10-22 19:28","pubTimestamp":1729596481,"startTime":"0","endTime":"0","summary":"智通财经APP讯,艾迪药业(688488.SH)公告,公司董事兼副总裁王军通过集中竞价减持的方式累计减持公司股份69.21万股,减持股份数量占公司总股本的0.16%,本次减持计划已实施完毕。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1197616.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0262","688488"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-07-20","address":"江苏省扬州市邗江区新甘泉西路69号","stockEarnings":[{"period":"1week","weight":-0.0129},{"period":"1month","weight":0.035},{"period":"3month","weight":0.2037},{"period":"6month","weight":-0.3794},{"period":"1year","weight":-0.326},{"period":"ytd","weight":-0.2678}],"companyName":"江苏艾迪药业股份有限公司","boardCode":"AI0041","perCapita":"41456股","boardName":"其他制造业","registeredCapital":"42078万元","compareEarnings":[{"period":"1week","weight":-0.0191},{"period":"1month","weight":-0.0108},{"period":"3month","weight":0.1446},{"period":"6month","weight":0.0577},{"period":"1year","weight":0.0671},{"period":"ytd","weight":0.0982}],"survey":" 江苏艾迪药业股份有限公司主营业务以为HIV为主的抗病毒业务及人源蛋白业务。主要产品有乌司他丁、尤瑞克林、尿激酶等人源蛋白产品以及蜡样芽孢杆菌片、番泻叶颗粒、头孢拉定胶囊等制剂。公司荣获“2023年度扬州民营企业创新20强”、荣登“2022年度扬州市创新型企业50强”名单及“2022年度中国小分子药物企业创新力TOP30排行榜”。","serverTime":1732303520059,"listedPrice":13.99,"stockholders":"10150人(较上一季度增加7.06%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"艾迪药业(688488)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供艾迪药业(688488)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"艾迪药业,688488,艾迪药业股票,艾迪药业股票老虎,艾迪药业股票老虎国际,艾迪药业行情,艾迪药业股票行情,艾迪药业股价,艾迪药业股市,艾迪药业股票价格,艾迪药业股票交易,艾迪药业股票购买,艾迪药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"艾迪药业(688488)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供艾迪药业(688488)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}